Chemo-enzymatic cascade processes are invaluable due to their ability to rapidly construct high-value products from available feedstock chemicals in a one-pot relay manner. In an article, author is Sudo, Roberto T., once mentioned the application of 622-26-4, Name is 2-(Piperidin-4-yl)ethanol, molecular formula is C7H15NO, molecular weight is 129.2001, MDL number is MFCD00006008, category is piperidines. Now introduce a scientific discovery about this category, COA of Formula: C7H15NO.
Novel agonist of alpha(4)beta(2)* neuronal nicotinic receptor with antinociceptive efficacy in rodent models of acute and chronic pain
Objective: To demonstrate the antinociceptive and antihypersensitivity mechanisms of Cris-104 (1- {2-[5-(4-fluoropheny1)-1H-pyrazol-4-yl]ethyl}piperidine), a novel selective alpha(4)beta(2)* nicotinic acetylcholine receptor (nAChR) agonist, in rodent acute/inflammatory and chronic pain models. Materials and methods: Hot-plate and formalin tests in mice were used to examine Cris-104-induced antinociceptive effects on thermal/inflammatory pain. Cris-104 effects on hypersensitivity, norepinephrine (NE) release in the spinal dorsal horn, and neuronal activity in the locus coeruleus (LC) were examined in rats with lumbar spinal nerve ligation using behavioral, microdialysis, and extracellular recording methods. Cris-104 effects on spontaneous locomotion were examined in an open-field test. Results: Cris-104 induced dose-dependent antinociception effects in hot-plate and formalin tests, and these effects were blocked by the general nAChR antagonist mecamylamine, the selective alpha(4)beta(2)* nAChR antagonist dihydro-beta-erythroidine, and the alpha(2)-adrenoceptor antagonist yohimbine, but not by the alpha(2)-adrenoceptor antagonist prazosin. Systemic and spinally perfused Cris-104 increased NE concentrations in microdialysates from the spinal cord in both normal and SNL, rats. Systemic Cris-104 increased neuronal activity in the LC of normal rats. Mecamylamine blocked the effects of Cris-104 on spinal NE release and LC neuronal activity. Systemic Cris-104 did not affect locomotor activity significantly. Conclusion: The alpha(4)beta(2) neuronal nAChR agonist, Cris-104, was effective for treatment of pain via descending noradrenergic inhibition of pain signaling.
Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 622-26-4, COA of Formula: C7H15NO.
Reference:
Piperidine – Wikipedia,
,Piperidine | C5H11N – PubChem